Other product sales, which include products from chronic hepatitis B virus (HBV), cardiovascular, oncology and other categories inclusive of Vemlidy (tenofovir alafenamide 25 mg), Viread (tenofovir disoproxil fumarate 300 mg), Letairis (ambrisentan 5 mg and 10 mg), Ranexa(ranolazine 500 mg and 1000 mg), Zydelig (idelalisib 150 mg), AmBisome
(amphotericin B liposome for injection 50 mg/vial) and Cayston (aztreonam for inhalation solution 75 mg/vial), were $604 million for the second quarter of 2019 compared to $807 million for the same period in 2018.
Other product sales, which include products from Gilead's chronic hepatitis B virus (HBV), cardiovascular, oncology and other categories inclusive of Vemlidy, Viread, Letairis, Ranexa, Zydelig and AmBisome
, were $797 million in the quarter, down 10%.
Activities of hexadecylphosphocholine (miltefosine), AmBisome
, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Liposomal amphotericin B (Ambisome
) in the treatment of complicated Kala-azar under the field conditions.
Safety and efficacy of short course combination regimens with AmBisome
, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
We treated the patient with liposomal amphotericin B (AmBisome
[Gilead Sciences Ltd., London, UK) at a dose of 3 mg/kg given on days 1-5, and 7-day courses beginning on days 10 and 20.
Pappas et al., "Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome
) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study," Antimicrobial Agents and Chemotherapy, vol.
After assessing the clinical and laboratory findings of patients, 4 liposomal amphotericin-B (Ambisome
; Gilead Turkey, Besiktas, Istanbul, Turkey) 3 mg/kg/day was started when no response was obtained to the empiric antibiotherapy for 7 days in the auto-HSCT group and for 5 days in the allo-HSCT group.
McEvoy et al., "Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome
) in neutropenic patients," Antimicrobial Agents and Chemotherapy, vol.
Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (ambisome
) and DAMB.